Latest On AIkido Pharma Inc (SPEX):
About AIkido Pharma Inc (SPEX):
Spherix Incorporated, a biotechnology development company, focuses on developing small-molecule anti-cancer therapeutics. The company engages in the development of therapeutic drugs for the treatment of various cancers including pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia (ALL). Its portfolio includes KPC-34 for the treatment of acute myeloid leukemia and acute lymphoblastic leukemia; and DHA-dFdC drug for chemotherapy treatment and pancreatic cancer. Spherix Incorporated was founded in 1967 and is based in New York, New York.
General
- Name AIkido Pharma Inc
- Symbol SPEX
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorOther
- IndustryOther
- Full Time Employees 3
- Fiscal Year EndDecember
- Gic SectorIndustrials
- Gic GroupCommercial & Professional Services
- Gic IndustryProfessional Services
- Gic SubIndustryResearch & Consulting Services
- Web URLwww.spherix.com
Valuation
- Trailing PE 2.04
- Price/Sales (Trailing 12 Mt.) 207.4
- Price/Book (Most Recent Quarter) 2.46
- Enterprise Value Revenue 2775.66
Financials
- Most Recent Quarter 0000-00-00
- Earnings Per Share $0.15
- Revenue Per Share $0
- Gross Profit 9000
- Quarterly Earnings Growth 0%
Highlights
- Market Capitalization 22.45 million
- EBITDA -1900500
- Analyst Target Price $19
- Book Value Per Share $2.18
Share Statistics
- % Held by Insiders <1%
- Shares Short 1244
- Shares Short Prior Month 16077
Technicals
- 52 Week High $0.93
- 52 Week Low $0.48
- 50 Day Moving Average 0.57
- 200 Day Moving Average 1.14
Dividends
- Dividend Date N/A
- ExDividend Date N/A
AIkido Pharma Inc (SPEX) Dividend Calendar:
Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
---|
AIkido Pharma Inc (SPEX) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
---|---|---|---|---|---|
2018-12-31 | 2019-03-12 | $28000 | $2.74 | ||
2018-09-30 | 2018-11-20 | $N/A | -$0.94 | ||
2018-06-30 | 2018-08-14 | $N/A | -$0.20 | ||
2018-03-31 | 2018-05-16 | $N/A | -$0.96 | ||
2017-12-31 | 2018-03-26 | $284000 | -$0.67 | ||
2017-09-30 | 2017-11-14 | $314000 | $0.32 | ||
2017-06-30 | 2017-08-15 | $311000 | -$1.59 | ||
2017-03-31 | 2017-05-16 | $327000 | -$0.79 | ||
2016-09-30 | 2016-11-11 | $314000 | -$0.46 | ||
2016-06-30 | 2016-08-12 | $177000 | $39.13 | ||
2016-03-31 | 2016-05-10 | $72000 | -$1.12 | ||
2015-12-31 | 2016-03-30 | $31000 | $8.06 | ||
2015-09-30 | 2015-11-13 | $N/A | -$6.64 | ||
2015-06-30 | 2015-08-18 | $-2000 | -$113.73 | ||
2015-03-31 | 2015-05-22 | $2000 | -$11.53 | ||
2014-09-30 | 2014-11-17 | $20000 | -$14.80 | ||
2014-06-30 | 2014-08-18 | $3000 | -$55.34 | ||
2014-03-31 | 2014-05-15 | $4000 | -$134.25 | ||
2013-09-30 | 2013-11-18 | $2000 | -$559.52 | ||
2013-06-30 | 2013-08-19 | $213 | -$92.36 | ||
2013-03-31 | 2013-05-16 | $6000 | -$431.85 | ||
2012-09-30 | 2012-11-20 | $194301 | -$297.64 | ||
2012-06-30 | 2012-08-13 | $206103 | -$290.24 | ||
2012-03-31 | 2012-05-15 | $209562 | -$501.57 | ||
2011-12-31 | 2012-03-28 | -$799.13 | |||
2011-09-30 | 2011-11-11 | $198464 | -$575.61 | ||
2011-06-30 | 2011-08-12 | $186050 | -$638.90 | ||
2011-03-31 | 2011-05-20 | -$155.21 | |||
2010-12-31 | 2011-03-30 | -$796.98 | |||
2010-09-30 | 2010-11-15 | -$2,014.60 | |||
2010-06-30 | 2010-08-17 | -$2,408.37 | |||
2010-03-31 | 2010-05-21 | -$2,022.54 | |||
2009-12-31 | 2010-03-29 | -$3,705.42 | |||
2009-09-30 | 2009-11-17 | -$2,416.06 | |||
2009-06-30 | 2009-08-17 | -$1,748.65 | |||
2009-03-31 | 2009-05-15 | -$2,324.07 | |||
2008-12-31 | 2009-03-30 | $895.85 | |||
2008-09-30 | 2008-11-14 | -$1,952.14 | |||
2008-06-30 | 2008-08-14 | -$1,351.52 | |||
2008-03-31 | 2008-05-14 | -$2,159.04 | |||
2007-12-31 | 2008-03-04 | -$2,477.01 | |||
2007-09-30 | 2007-11-16 | $5,982.50 | |||
2007-06-30 | 2007-08-14 | -$1,977.76 | |||
2007-03-31 | 2007-05-14 | -$2,642.87 | |||
2006-12-31 | 2007-03-30 | $4,539.69 | |||
2006-09-30 | 2006-11-13 | -$11.17 | |||
2006-06-30 | 2006-08-11 | $280.72 | |||
2006-03-31 | 2006-05-12 | -$663.05 | |||
2005-12-31 | 2006-03-30 | -$3,070.04 | |||
2005-09-30 | 2005-11-10 | $382.43 | |||
2005-06-30 | 2005-08-12 | $308.09 | |||
2005-03-31 | 2005-05-13 | -$1,450.34 | |||
2004-12-31 | 2005-03-29 | -$3,749.40 | |||
2004-09-30 | 2004-11-10 | $396.23 | |||
2004-06-30 | 2004-08-10 | $259.30 | |||
2004-03-31 | 2004-05-13 | -$757.06 | |||
2003-12-31 | 2004-03-30 | -$1,422.69 | |||
2003-09-30 | 2003-11-14 | -$163.39 | |||
2003-06-30 | 2003-08-08 | -$644.56 | |||
2003-03-31 | 2003-03-31 | -$976.57 | |||
2002-09-30 | 2002-09-30 | $195.13 | |||
2002-06-30 | 2002-06-30 | -$426.89 | |||
2002-03-31 | 2002-03-31 | -$1,655.20 | |||
2001-09-30 | 2001-09-30 | $2,068.29 | |||
2001-06-30 | 2001-06-30 | $416.12 | |||
2001-03-31 | 2001-03-31 | -$236.30 | |||
2000-09-30 | 2000-09-30 | $663.93 | |||
2000-06-30 | 2000-06-30 | $553.72 | |||
2000-03-31 | 2000-03-31 | $1,426.07 | |||
1999-09-30 | 1999-09-30 | $23.36 | |||
1999-06-30 | 1999-06-30 | -$1,444.44 | |||
1999-03-31 | 1999-03-31 | -$1,737.46 | |||
1998-09-30 | 1998-09-30 | -$650.55 | |||
1998-06-30 | 1998-06-30 | $399.95 | |||
1998-03-31 | 1998-03-31 | -$90.06 |
AIkido Pharma Inc (SPEX) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
Date |
---|
Research Development |
Income Before Tax |
Selling General Administrative |
Gross Profit |
Ebit |
Operating Income |
Income Tax Expense |
Total Revenue |
Cost of Revenue |
Total Other Income Expense Net |
Net Income From Continuing Operations |
Net Income Applicable to Common Shares |
Cash Flow:
Date |
---|
Investments |
Change to Liabilities |
Total Cash Flow from Investing Activities |
Net Borrowings |
Total Cash Flow from Financial Activities |
Change to Operating Activities |
Change in Cash |
Total Cash from Operating Activities |
Depreciation |
Other Cash Flow from Investing Activities |
Change to Inventory |
Change to Account Receivables |
Other Cash Flow from Financing Activities |
Change to Net Income |
Capital Expenditures |
Balance Sheet:
Date |
---|
Total Liabailities |
Total Stockholder Equity |
Other Current Liabilities |
Total Assets |
Common Stock |
Other Current Assets |
Retained Earnings |
Other Liabilities |
Other Assets |
Cash |
Total Current Liabilities |
Other Stockholder Equity |
Property, Plant & Equipment |
Total Current Assets |
Long Term Investments |
Net Tangible Assets |
Short Term Investments |
Long Term Debt |
Inventory |
Accounts Payable |
AIkido Pharma Inc (SPEX) Chart:
AIkido Pharma Inc (SPEX) News:
Below you will find a list of latest news for AIkido Pharma Inc (SPEX) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
AIkido Pharma Inc (SPEX) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
---|
AIkido Pharma Inc (SPEX) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
Date | Form Type | Form Name | Link |
---|---|---|---|
2018-01-18 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/12239/000000000018001743/0000000000-18-001743-index.htm |
2019-07-02 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/12239/000000000019010686/0000000000-19-010686-index.htm |
2019-07-25 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/12239/000000000019011548/0000000000-19-011548-index.htm |
2020-02-11 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/12239/000000000020001269/0000000000-20-001269-index.htm |
2020-03-13 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/12239/000091957420002437/0000919574-20-002437-index.htm |
2020-02-28 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/12239/000110465920026927/0001104659-20-026927-index.htm |
2020-02-28 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/12239/000110465920026941/0001104659-20-026941-index.htm |
2020-04-24 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/12239/000110465920050835/0001104659-20-050835-index.htm |
2019-06-07 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/12239/000121390019010256/0001213900-19-010256-index.htm |
2019-06-07 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/12239/000121390019010258/0001213900-19-010258-index.htm |
2019-06-19 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/12239/000121390019010992/0001213900-19-010992-index.htm |
2019-06-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/12239/000121390019010999/0001213900-19-010999-index.htm |
2019-06-19 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/12239/000121390019011000/0001213900-19-011000-index.htm |
2019-07-24 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/12239/000121390019013493/0001213900-19-013493-index.htm |
2019-07-24 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/12239/000121390019013495/0001213900-19-013495-index.htm |
2019-08-09 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/12239/000121390019015200/0001213900-19-015200-index.htm |
2019-08-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/12239/000121390019015209/0001213900-19-015209-index.htm |
2019-08-12 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/12239/000121390019015210/0001213900-19-015210-index.htm |
2019-08-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/12239/000121390019015803/0001213900-19-015803-index.htm |
2019-08-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/12239/000121390019016336/0001213900-19-016336-index.htm |
2019-08-19 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/12239/000121390019016338/0001213900-19-016338-index.htm |
2019-08-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/12239/000121390019016609/0001213900-19-016609-index.htm |
2019-08-23 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/12239/000121390019016610/0001213900-19-016610-index.htm |
2019-09-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/12239/000121390019017374/0001213900-19-017374-index.htm |
2019-10-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/12239/000121390019020194/0001213900-19-020194-index.htm |
2019-11-12 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/12239/000121390019022956/0001213900-19-022956-index.htm |
2019-12-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/12239/000121390019025719/0001213900-19-025719-index.htm |
2020-01-14 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/12239/000121390020000986/0001213900-20-000986-index.htm |
2020-01-31 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/12239/000121390020002270/0001213900-20-002270-index.htm |
2020-02-03 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/12239/000121390020002309/0001213900-20-002309-index.htm |
2020-02-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/12239/000121390020004633/0001213900-20-004633-index.htm |
2020-02-27 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/12239/000121390020004859/0001213900-20-004859-index.htm |
2020-02-28 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/12239/000121390020005069/0001213900-20-005069-index.htm |
2020-02-28 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/12239/000121390020005072/0001213900-20-005072-index.htm |
2020-03-02 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/12239/000121390020005166/0001213900-20-005166-index.htm |
2020-03-02 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/12239/000121390020005168/0001213900-20-005168-index.htm |
2020-03-04 | 424B4 | Prospectus [Rule 424(b)(4)] | https://www.sec.gov/Archives/edgar/data/12239/000121390020005413/0001213900-20-005413-index.htm |
2020-03-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/12239/000121390020005690/0001213900-20-005690-index.htm |
2020-03-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/12239/000121390020005756/0001213900-20-005756-index.htm |
2020-03-10 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/12239/000121390020005832/0001213900-20-005832-index.htm |
2020-03-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/12239/000121390020005904/0001213900-20-005904-index.htm |
2020-03-12 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/12239/000121390020006049/0001213900-20-006049-index.htm |
2020-03-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/12239/000121390020007335/0001213900-20-007335-index.htm |
2020-03-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/12239/000121390020007481/0001213900-20-007481-index.htm |
2020-03-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/12239/000121390020007482/0001213900-20-007482-index.htm |
2020-03-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/12239/000121390020007744/0001213900-20-007744-index.htm |
2020-04-15 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/12239/000121390020009236/0001213900-20-009236-index.htm |
2020-04-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/12239/000121390020009243/0001213900-20-009243-index.htm |
2020-04-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/12239/000121390020009553/0001213900-20-009553-index.htm |
2020-04-23 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/12239/000121390020009937/0001213900-20-009937-index.htm |
2020-05-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/12239/000121390020010782/0001213900-20-010782-index.htm |
2020-05-11 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/12239/000121390020011695/0001213900-20-011695-index.htm |
2020-05-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/12239/000121390020012254/0001213900-20-012254-index.htm |
2020-05-19 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/12239/000121390020012985/0001213900-20-012985-index.htm |
2020-05-19 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/12239/000121390020012987/0001213900-20-012987-index.htm |
2020-04-24 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/12239/000138713120004085/0001387131-20-004085-index.htm |
2020-04-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/12239/000153561020000087/0001535610-20-000087-index.htm |
2017-06-12 | 8-A12G/A | Registration of securities [Section 12(g)] | https://www.sec.gov/Archives/edgar/data/12239/000161577417003104/0001615774-17-003104-index.htm |
2017-06-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/12239/000161577417003253/0001615774-17-003253-index.htm |
2017-07-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/12239/000161577417003472/0001615774-17-003472-index.htm |
2017-07-05 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/12239/000161577417003480/0001615774-17-003480-index.htm |
2017-07-17 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/12239/000161577417003655/0001615774-17-003655-index.htm |
2017-07-17 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/12239/000161577417003661/0001615774-17-003661-index.htm |
2017-07-17 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/12239/000161577417003663/0001615774-17-003663-index.htm |
2017-07-18 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/12239/000161577417003694/0001615774-17-003694-index.htm |
2017-07-18 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/12239/000161577417003701/0001615774-17-003701-index.htm |
2017-07-18 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/12239/000161577417003702/0001615774-17-003702-index.htm |
2017-07-18 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/12239/000161577417003703/0001615774-17-003703-index.htm |
2017-07-20 | 424B4 | Prospectus [Rule 424(b)(4)] | https://www.sec.gov/Archives/edgar/data/12239/000161577417003742/0001615774-17-003742-index.htm |
2017-07-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/12239/000161577417003768/0001615774-17-003768-index.htm |
2017-08-11 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/12239/000161577417004286/0001615774-17-004286-index.htm |
2017-10-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/12239/000161577417005899/0001615774-17-005899-index.htm |
2017-11-07 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/12239/000161577417006278/0001615774-17-006278-index.htm |
2017-11-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/12239/000161577417006703/0001615774-17-006703-index.htm |
2017-12-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/12239/000161577417007311/0001615774-17-007311-index.htm |
2018-01-09 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/12239/000161577418000227/0001615774-18-000227-index.htm |
2018-01-18 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/12239/000161577418000400/0001615774-18-000400-index.htm |
2018-02-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/12239/000161577418001338/0001615774-18-001338-index.htm |
2018-02-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/12239/000161577418001339/0001615774-18-001339-index.htm |
2018-02-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/12239/000161577418001340/0001615774-18-001340-index.htm |
2018-03-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/12239/000161577418001879/0001615774-18-001879-index.htm |
2018-03-14 | 425 | Prospectuses and communications, business combinations | https://www.sec.gov/Archives/edgar/data/12239/000161577418001880/0001615774-18-001880-index.htm |
2018-03-15 | 424B2 | Prospectus [Rule 424(b)(2)] | https://www.sec.gov/Archives/edgar/data/12239/000161577418001890/0001615774-18-001890-index.htm |
2018-03-16 | 424B2 | Prospectus [Rule 424(b)(2)] | https://www.sec.gov/Archives/edgar/data/12239/000161577418001950/0001615774-18-001950-index.htm |
2018-03-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/12239/000161577418001979/0001615774-18-001979-index.htm |
2018-03-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/12239/000161577418002153/0001615774-18-002153-index.htm |
2018-03-30 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/12239/000161577418002232/0001615774-18-002232-index.htm |
2018-04-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/12239/000161577418002483/0001615774-18-002483-index.htm |
2018-04-09 | 425 | Prospectuses and communications, business combinations | https://www.sec.gov/Archives/edgar/data/12239/000161577418002484/0001615774-18-002484-index.htm |
2018-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/12239/000161577418003380/0001615774-18-003380-index.htm |
2018-05-07 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/12239/000161577418003381/0001615774-18-003381-index.htm |
2018-05-07 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/12239/000161577418003421/0001615774-18-003421-index.htm |
2018-05-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/12239/000161577418003423/0001615774-18-003423-index.htm |
2018-05-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/12239/000161577418003514/0001615774-18-003514-index.htm |
2018-05-15 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/12239/000161577418003870/0001615774-18-003870-index.htm |
2018-08-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/12239/000161577418008063/0001615774-18-008063-index.htm |
2018-10-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/12239/000161577418010961/0001615774-18-010961-index.htm |
2018-10-16 | 425 | Prospectuses and communications, business combinations | https://www.sec.gov/Archives/edgar/data/12239/000161577418010962/0001615774-18-010962-index.htm |
2018-11-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/12239/000161577418012680/0001615774-18-012680-index.htm |
2018-11-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/12239/000161577418013017/0001615774-18-013017-index.htm |
2018-11-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/12239/000161577418013019/0001615774-18-013019-index.htm |
2018-11-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/12239/000161577418013505/0001615774-18-013505-index.htm |
2019-01-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/12239/000161577419000715/0001615774-19-000715-index.htm |
2019-02-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/12239/000161577419001998/0001615774-19-001998-index.htm |
2019-02-28 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/12239/000161577419003246/0001615774-19-003246-index.htm |
2019-03-12 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/12239/000161577419003916/0001615774-19-003916-index.htm |
2019-03-12 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/12239/000161577419003918/0001615774-19-003918-index.htm |
2019-03-13 | DEFR14A | Revised definitive proxy soliciting materials | https://www.sec.gov/Archives/edgar/data/12239/000161577419004013/0001615774-19-004013-index.htm |
2019-04-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/12239/000161577419005837/0001615774-19-005837-index.htm |
2019-05-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/12239/000161577419007388/0001615774-19-007388-index.htm |
2019-05-15 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/12239/000161577419007947/0001615774-19-007947-index.htm |
2019-05-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/12239/000161577419007976/0001615774-19-007976-index.htm |
2019-05-16 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/12239/000161577419007977/0001615774-19-007977-index.htm |
2019-05-31 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/12239/000161577419009013/0001615774-19-009013-index.htm |
2019-05-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/12239/000161577419009017/0001615774-19-009017-index.htm |
2017-07-18 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/12239/999999999517001844/9999999995-17-001844-index.htm |
2018-01-19 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/12239/999999999518000173/9999999995-18-000173-index.htm |
2020-03-03 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/12239/999999999520000458/9999999995-20-000458-index.htm |
AIkido Pharma Inc (SPEX) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of AIkido Pharma Inc (SPEX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: < 1%Institutional Ownership: < 1%
Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
---|---|---|---|---|---|---|---|---|
2018-02-16 | Eric Weisblum | Director | Buy | 20,000.00 | 20,000.00 | https://www.sec.gov/Archives/edgar/data/12239/000161577418001339/0001615774-18-001339-index.htm | ||
2018-02-16 | TIM S LEDWICK | Director | Buy | 20,000.00 | 20,000.00 | https://www.sec.gov/Archives/edgar/data/12239/000161577418001340/0001615774-18-001340-index.htm | ||
2018-02-16 | Robert J VanderZanden | Director | Buy | 20,000.00 | 21,007.00 | https://www.sec.gov/Archives/edgar/data/12239/000161577418001338/0001615774-18-001338-index.htm | ||
2018-11-19 | TIM S LEDWICK | Director | Buy | 10,000.00 | 0.90 | 9,000.00 | 30,000.00 | https://www.sec.gov/Archives/edgar/data/12239/000161577418013019/0001615774-18-013019-index.htm |
2018-11-19 | Anthony Hayes | Chief Executive Officer | Buy | 2,000.00 | 0.90 | 1,800.00 | 44,183.00 | https://www.sec.gov/Archives/edgar/data/12239/000161577418013017/0001615774-18-013017-index.htm |
2018-11-19 | Anthony Hayes | Chief Executive Officer | Buy | 8,000.00 | 0.88 | 7,040.00 | 52,183.00 | https://www.sec.gov/Archives/edgar/data/12239/000161577418013017/0001615774-18-013017-index.htm |